Neurology

Zeto Announces Winners of Clinical Trial Sponsorship Program

SANTA CLARA, Calif., June 25, 2024 /PRNewswire/ -- Zeto, Inc., an award-winning medical technology firm, is proud to announce the…

1 year ago

eVisit Acquires UPMC’s Inpatient Teleconsult Technology and Secures Investments from UPMC Enterprises and MedStar Health to Expand Innovative Partnerships and Capabilities

Organizations also join growing list of eVisit co-development and advisory collaborators, strengthening the industry-leading platform recognized as "Best in KLAS" for…

1 year ago

Oragenics, Inc. Announces Pricing of Public Offering

SARASOTA, Fla., June 25, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal…

1 year ago

Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood Advances

WARREN, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage…

1 year ago

Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program

Just - Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD's Manufacturing Optimization ProgramManufacturing solution…

1 year ago

HealthTech Connex Awarded $1 Million from The Government of Canada to Revolutionize Concussion Detection and Recovery

The NeuroCatch Platform, a subsidiary of HealthTech Connex, offers an objective evaluation of cognitive function, delivered in minutes at the…

1 year ago

Oragenics, Inc. Announces NYSE American Acceptance of Plan of Compliance

SARASOTA, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal…

1 year ago

Watertown Regional Medical Center Partners with HOPCo To Enhance Orthopedic and Spine Services

WATERTOWN, Wis. and PHOENIX, Ariz., June 19, 2024 /PRNewswire/ -- Watertown Regional Medical Center (WRMC) and Healthcare Outcomes Performance Company…

1 year ago

Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy

- RMAT designation follows positive data update from the ongoing Phase 1/2 clinical trial of NRTX-1001 cell therapy, demonstrating a…

1 year ago

Tevogen.AI Head Discusses Company’s Bold Strategy to Shape the Future of T Cell Therapies at Longwood Spring MIT Conference

WARREN, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage…

1 year ago